News & Analysis as of September 19, 2024

Inventions › AstraZeneca

+ Follow

Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions (Podcast)
#WorkforceWednesday: Invention Ownership - Why the Tense Matters in Employee IP Provisions - Employment Law This Week® - Spilling Secrets Podcast
Patent Dual-application Strategy in China
How to Write a Technical Disclosure for Patent Drafting
The Utility Model System in China
Williams Mullen Manufacturing Edge: IP Considerations for Manufacturers
Risk Prevention Strategies: Ownership of Employee-Developed Inventions and Intellectual Property
Nonpublication Requests For Patent Applications Part 3: Pitfalls
Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?
What Is a Patent and How Do I Get One
Nonpublication Requests For Patent Applications Part 1: Benefits
Monthly Minute | Commercialization of an Invention
[IP Hot Topics Podcast] Innovation Conversations: Walter Isaacson, Part 2
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Patent Searching
PODCAST: Trending Now An IP Podcast - Patent Office Secrecy Orders
IP Monthly Minute | February 2020
JONES DAY TALKS®: When AI Invents: Two Applications Test U.S. Patent Law
6 Key Takeaways | Considerations Before Relying on AIA Prior User Rights

Think Twice When Writing About the “Invention” in a Patent Application

Mintz - Intellectual Property Viewpoints on 10/9/2014

Two recent Federal Circuit decisions emphasize that characterizing the “present invention” by using that term in a U.S. patent application specification can limit the claims according to that characterization. See...more

1 Results

View per page

Page: of 1

Inventions › AstraZeneca

Think Twice When Writing About the “Invention” in a Patent Application

"My best business intelligence, in one easy email…"